reference/20625321

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20625321

Outgoing Links

Predicate	Object
contentType	Comparative Study\|Journal Article\|Research Support, U.S. Gov't, Non-P.H.S.
endingPage	163
issn	0928-0987
issueIdentifier	2
pageRange	155-163
publicationName	European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
startingPage	155
bibliographicCitation	Kulvik M, Vähätalo J, Buchar E, Färkkilä M, Järviluoma E, Jääskeläinen J, Křiž O, Laakso J, Rasilainen M, Ruokonen I, Kallio M. Clinical implementation of 4-dihydroxyborylphenylalanine synthesised by an asymmetric pathway. European Journal of Pharmaceutical Sciences. 2003 Feb;18(2):155–63. doi: 10.1016/s0928-0987(02)00256-7.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6f7891866f38beb0f021538d5086d3ea http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_eb6041483013ee90c1670066e6e11898 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_98c8f61d346dcb4c735dc217d8406b4a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1cf0a52d7b5b0a419688926b732e1906 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cca575dec4f8e73a070af48fa7fe4f3d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0952fa56cb6c1ec78079ae06318a768a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3a5f61e6435f006bdc4a3f9d4b2a6caf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2c286790c796431c2af02aa7d91dff43 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_560bc1059376de33e97791264b6ca1d6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f66840ab7ef47022b322a9c9f6c7e433 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4e02b3f1551816c22194d649afd03720
date	200302
identifier	https://pubmed.ncbi.nlm.nih.gov/12594009 https://doi.org/10.1016/s0928-0987%2802%2900256-7
isPartOf	https://portal.issn.org/resource/ISSN/0928-0987 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21091
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Clinical implementation of 4-dihydroxyborylphenylalanine synthesised by an asymmetric pathway
discusses	http://id.nlm.nih.gov/mesh/M0002832 http://id.nlm.nih.gov/mesh/M0400516 http://id.nlm.nih.gov/mesh/M0016544
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D001896Q000138 http://id.nlm.nih.gov/mesh/D001932Q000188 http://id.nlm.nih.gov/mesh/D013678Q000379 http://id.nlm.nih.gov/mesh/D010649Q000627 http://id.nlm.nih.gov/mesh/D001896Q000627 http://id.nlm.nih.gov/mesh/D010649Q000138 http://id.nlm.nih.gov/mesh/D010649Q000031
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D004353Q000379 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D002986Q000706 http://id.nlm.nih.gov/mesh/D051381 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D017207 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D001932Q000097 http://id.nlm.nih.gov/mesh/D005260
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID97370 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6623 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2723872 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID150315 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6140 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462311 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6057 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6837 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7099

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128694259 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129862661 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127654813 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129122856

Total number of triples: 64.